Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Vivos Therapeutics (VVOS) Gross Profit (2020 - 2025)

Vivos Therapeutics has reported Gross Profit over the past 6 years, most recently at $3.0 million for Q4 2025.

  • Quarterly Gross Profit rose 42.49% to $3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Dec 2025, up 16.91% year-over-year, with the annual reading at $10.5 million for FY2025, 16.89% up from the prior year.
  • Gross Profit was $3.0 million for Q4 2025 at Vivos Therapeutics, down from $3.9 million in the prior quarter.
  • Over five years, Gross Profit peaked at $3.9 million in Q3 2025 and troughed at $1.5 million in Q1 2025.
  • The 5-year median for Gross Profit is $2.4 million (2022), against an average of $2.5 million.
  • Year-over-year, Gross Profit crashed 30.01% in 2023 and then soared 68.68% in 2025.
  • A 5-year view of Gross Profit shows it stood at $3.1 million in 2021, then dropped by 23.27% to $2.4 million in 2022, then dropped by 12.37% to $2.1 million in 2023, then increased by 0.38% to $2.1 million in 2024, then skyrocketed by 42.49% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Gross Profit are $3.0 million (Q4 2025), $3.9 million (Q3 2025), and $2.1 million (Q2 2025).